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Abstract: The present publication reports the purification effort of two natural bone blocks, that is, an
allogeneic bone block (maxgraft®, botiss biomaterials GmbH, Zossen, Germany) and a xenogeneic
block (SMARTBONE®, IBI S.A., Mezzovico-Vira, Switzerland) in addition to previously published
results based on histology. Furthermore, specialized scanning electron microscopy (SEM) and in vitro
analyses (XTT, BrdU, LDH) for testing of the cytocompatibility based on ISO 10993-5/-12 have been
conducted. The microscopic analyses showed that both bone blocks possess a trabecular structure
with a lamellar subarrangement. In the case of the xenogeneic bone block, only minor remnants of
collagenous structures were found, while in contrast high amounts of collagen were found associated
with the allogeneic bone matrix. Furthermore, only island-like remnants of the polymer coating
in case of the xenogeneic bone substitute seemed to be detectable. Finally, no remaining cells or
cellular remnants were found in both bone blocks. The in vitro analyses showed that both bone
blocks are biocompatible. Altogether, the purification level of both bone blocks seems to be favorable
for bone tissue regeneration without the risk for inflammatory responses or graft rejection. Moreover,
the analysis of the maxgraft® bone block showed that the underlying purification process allows
for preserving not only the calcified bone matrix but also high amounts of the intertrabecular
collagen matrix.
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1. Introduction
In dentistry and many surgical disciplines, different allogeneic and xenogeneic bone substitutes
are available [1,2]. This material class, including the so-called naturally derived bone substitutes, is
expected to exhibit favorable regenerative properties based on the “natural” chemical composition and
ultrastructure of bone tissue, which is supposed to be comparable to autologous bone transplants [3].
However, a prerequisite for their safe and effective clinical application is the purification of the precursor
tissue from all immunologically effective components such as the different cell types or proteins as well
as possibly existing pathogens [4,5]. In this context, the overall aim of every purification technology
is the preservation of the ultrastructure of the bone matrix in combination with collagen from the
intertrabecular tissue to optimally support the process of bone regeneration and associated healing
factors such as the implant bed vascularization [3,5,6].
Interestingly, a variety of purification techniques with different physical and/or chemical methods
is applied in case of the different commercially available bone blocks that should lead to the desired final
naturally derived biomaterial [3,7]. In this context, most of the material manufacturers have introduced
their own purification method and all of these methods are stated to fulfill the relevant rules, here the
standards and respective norms [7]. However, a previous study, focused on the analysis of the structure
of two allogeneic and three xenogeneic bone blocks to assess whether the components, which should
be removed, can be identified after applying conventional histological and histochemical staining
techniques, revealed wide variations between the purification efforts of the different commercially
available bone blocks [7]. In this study, the bone blocks were divided into four different groups due to
their respective ultrastructure of the bone matrix and organic contents (collagen, cell remnants) [7].
This classification varies from the complete purification of the natural bone substitute with loss of
its lamellar structure up to full conservation of the bone matrix with its lamellar and collagenous
structures. Although it is questionable if the observed remnants are still biologically active and may
cause inflammatory responses up to a complete rejection of the draft, a first selection based on even
such components may help clinicians to choose the right bone substitute material.
Based on these previously reported results, the aim of the present study was the additive analysis
of the ultrastructure of two other commercial available bone substitute blocks, the allogeneic block
maxgraft® (botiss biomaterials GmbH, Zossen, Germany) and the xenogeneic block SMARTBONE®
(IBI S.A., Mezzovico-Vira, Switzerland), with special respect to the microscopical analysis of the
calcified bone matrix as well as the detection of other components such as collagen and possible
organic remnants. Thereby, the surface and microstructure was additionally investigated by scanning
electron microscopy (SEM) and a standardized cytocompatibility analysis based on ISO 10993-5/-12 as
previously described [8].
2. Materials and Methods
2.1. Bone Blocks
2.1.1. Maxgraft® Block
Three samples of both bone blocks were histologically prepared and investigated to determine
the composition accordingly to the previous published methods [7,9,10]. Special focus was on the
detection of possible organic components, and thus on the control and assurance of the purification
quality as previously described [7].
The maxgraft® bonebuilder (botiss biomaterials GmbH, Berlin, Germany) is an allogeneic
cancellous bone substitute block derived from bone of femoral heads of living human donors from
Germany, Austrian and Swiss hospitals [9]. The bone blocks were prepared by the Cells + Tissuebank
Austria, a certified and audited non-profit organization, which is regulated by the Austrian health
ministry [11]. The purification of the bone tissue is stated to be in accordance with the respective
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European Directives and the Austrian Tissue Safety Act [9]. The effort of this purification process
should have been “validated by independent institutes” and by the Austria Health Ministry [11].
The purification process, the “C+TBA process”, is only described in more detail at the
manufacturer´s homepage [11]. It is described as a highly secure quality process, which should
be in compliance with highest quality standards leading to the inactivation of viruses and bacteria [11].
Furthermore, this purification process is described to include different physical and chemical purification
steps [11]. Initially, an ultrasonic-based removal of blood, cells and tissue components, which is stated
to mainly have an effect on the removal of fatty tissue, is applied as a physical method. Additionally,
chemical and oxidative cleaning steps using diethyl ether and ethanol with changing durations become
applied to inactivate both pathogens such as viruses and bacteria and also proteins [11]. Finally,
lyophilization and sterilization via gamma irradiation are applied, whereby the lyophilization is
described to preserve the natural tissue structure [11]. It is stated that the final composition of the bone
block includes the bone matrix and the bone tissue-specific collagen [11].
2.1.2. SMARTBONE® Block
The SMARTBONE® block (Industrie Biomediche Insubri SA, Mezzovico-Vira, Ticino, Switzerland)
is a xenogeneic bone substitute material, which is based on a bovine matrix that becomes combined
with “biodegradable polymers” and “cell nutrients” [12]. However, no detailed information is given
about the last-named additions. The “biodegradable polymer” is only described to be “the same as
used in resorbable sutures” [12]. Interestingly, different combinations have been described in the
patent application publication, while the combination with a polycaprolactone–polylactic (PLA/PCL)
co-polymer and hydrolyzed gelatin has been highlighted in the document [12]. Moreover, it is stated
that that the bone block includes bone tissue-specific collagen [12]. The bovine bone matrix originates
from animals from New Zealand, stated as a “bovine spongiform encephalopathy (BSE)free country”,
without further information about control mechanisms of the origin tissue and is only stated as “strictly
monitored according to ISO13485 prescriptions“ [12,13]. Also no detailed information about the
purification procedure is given on the package insert nor on the website, but after an email contact with
the manufacturer the process was described as “a patented method”, which includes “bone washing
and cleaning via chain-reaction and low-temperature (<50 ◦C) combined with undefined “chemical
processes”, which “not imply calcination“. Finally, “the starting material should not be ceramic-like”,
but “a natural material conserving the optimal mechanical properties of a bovine-originated mineral
structure”.
2.2. Scanning Electron Microscopy (SEM)
In order to characterize the surface morphology of both allogenic and xenogenic blocks, the
investigation was performed by means of a scanning electron microscope (CROSSBEAM XB 550L
ZEISS, Oberkochen, Germany) equipped with a charge compensator. This method allows surface
examination of uncoated non-conducting materials due to gas inflow through the needle of charge
compensator. The chosen parameters (accelerating voltage of 3 kV, working distance of 10–13 mm)
helped to prevent surface damage due to the scanning electron beam and provided information about
collagen remnants. The gas inflow was applied only for minimizing of charging effects; no images
were acquired.
2.3. Histological Analysis
Three samples of both bone blocks were histologically processed for further microscopic ex vivo
examination as described previously [7,9,10]. Briefly, all test samples were decalcified in tris-buffered
10% EDTA (Carl Roth, Karlsruhe, Germany), dehydrated in a series of increasing alcohol concentrations
(50, 70, 70, 80, 96, 100 and 100%) followed by the application of xylol and paraffin embedding.
Afterwards, histological sections of 3–5 µm thickness were prepared using a rotation microtome (Leica
RM2255, Wetzlar, Germany). The following histochemical stainings were prepared: hematoxylin
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and eosin (HE), Masson–Goldner’s trichrome, Giemsa and Sirius red, respectively. Osteoclasts were
determined by employing tartrate-resistant acid phosphatase (TRAP).
The histological analysis of the compositions of both bone blocks was also conducted following
previously described methods [7,9,10,14,15]. Briefly, the histological slides of the bone substitutes were
examined microscopically with respect to material characteristics such as the bone matrix structure
and components like collagen or cells/cell remnants independently and blind by the two first authors
using a light microscope Axio Scope.A1 (Carl Zeiss Microscopy GmbH, Jena, Germany). A Nikon
DS-Fi1 digital camera and a DS-L2 digital sight control unit (both Nikon, Tokyo, Japan) were used in
combination with the above-mentioned microscope to take the histological microphotographs.
2.4. Cytocompatibility Analyses
Cytocompatibility was determined based on EN ISO 10993-5/-12 regulations as described in
previous publications [8,16]. In the following, the experimental setup is described in brief. Overall,
n = 8 extracts of each test sample were processed.
2.4.1. Reference Materials (Positive and Negative Controls)
As a positive control material, RM-A, a polyurethane film containing 0.1% zinc
diethyldithiocarbamate (ZDEC) obtained from the Hatano Research Institute, Food and Drug Safety
Center, Tokyo, Japan, was employed. Titanium grade 4 was utilized as a negative control material.
All reference materials were prepared with identical surface areas as the material specimens and
sterilized likewise.
2.4.2. Cell Culture
L-929 mouse fibroblasts were acquired from the European Collection of Cell Culture, ECACC
(Salisbury, UK). Cells were cultured in a cell culture medium under cell culture conditions and passaged
at 80% confluency.
2.4.3. Extraction
All samples were extracted for 72 h at a surface to volume ratio of 3 cm2/mL in a cell culture
medium under cell culture conditions. The cell culture medium was incubated under comparable
conditions as a blind control (not displayed in results). After removal of the specimens, the remaining
extracts were centrifuged at 14,000 rpm for 10 min. The supernatants were used for the different assays
that described below.
2.4.4. Assay Procedure
The 96-well plates were seeded with 1 × 104 L929 cells/well in 100 µL cell culture medium and
incubated under cell culture conditions for 24 h before end of extraction. After delivering the cell
culture medium to the waste, 100 µL extracts were given to every cell well. After an incubation interval
of 24 h, BrdU and XTT assays were performed and supernatants were used for the LDH assay.
2.4.5. XTT-Assay
Cell Proliferation Kit II (XTT) (Roche Diagnostics, Mannheim, Germany) was utilized according
to the manufacturer's instructions. In brief, electron-coupling reagent was mixed with XTT labeling
reagent (1:50 dilution) and 50 µL of the mixture was added to the cells. Cells were incubated for a total
time interval of 4 h under cell culture conditions. The absorbances of 100 µL aliquots were determined
using a scanning multi-well spectrophotometer (Biorad 680, Hercules, CA, USA) with filters for 450 nm
and 650 nm (reference wavelength).
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2.4.6. BrdU-Assay
BrdU (colorimetric) test kit (Roche Diagnostics, Mannheim, Germany) was employed according
to the manufacturer's instructions. In brief, cells were fixed with FixDEnat at room temperature for
30 min after labelling with BrdU for a time interval of 2 h. Subsequently, anti-BrdU-POD antibody
was used for 1 h before washing several times in washing buffer. Tetramethylbenzidine (TMB) was
added for 20 min at room temperature before adding 25 µL 1 M H2SO4 stopping reaction. A scanning
multi-well spectrophotometer (ELISA reader) with 450 nm and 690 nm (reference wavelength) filters
was used to determine absorbances.
2.4.7. LDH-Assay
An LDH-Cytotoxicity Assay Kit II (BioVision, Milpitas, CA, USA) was employed according to the
instructions of the manufacturer. Accordingly, 10 µL of the extracted cell supernatants were mixed
with 100 µL LDH reaction reagent at room temperature for a time interval of 30 min. Thereafter,
stop solution was added and absorbances were determined by using a multi-well spectrophotometer
(ELISA reader) with filters for 450 nm and 650 nm (reference wavelength).
2.5. Statistical Analyses
Data were analyzed using ANOVA analysis with a post hoc Bonferroni test using GraphPad Prism
8.02 software (GraphPad Software Inc., San Diego, CA, USA). Statistical differences were specified as
follows: Significant for p-values less than 0.05 (* p ≤ 0.05) and highly significant if p-values were less
than 0.01 (** p ≤ 0.01).
3. Results
3.1. Microscopic Characterization
The microscopic characterization via scanning electron microscopy (SEM) and via histology
combinatorially revealed that both bone blocks possess a trabecular structure typical for the calcified
bone matrix (Figure 1A–D, Figures 2A and 3A). Moreover, both biomaterials exhibited a lamellar
substructure, and neither cells nor cell remnants were observable within the osteocyte lacunae nor
at their outer surfaces (Figure 1, Figure 2B,C and Figure 3B,C). No signs of tartrate-resistant acid
phosphatase (TRAP)-positive cells were observed in case of both bone substitute materials (data
not shown).
Furthermore, a few fragments of the bone matrix were observable within the trabecular interspaces
in case of the allogeneic bone block (Figure 2A), while within the intertrabecular interspaces of the
xenogeneic bone block high numbers of matrix fragments were observed (Figure 3A).
Additionally, both microscopy methods showed that high amounts of the intertrabecular
collagenous matrix were observable in all analyzed allogeneic bone blocks (Figure 1A,C, and
Figure 2A,C). The morphology of the collagenous structures was similar to fatty tissue and connective
tissue (Figure 2C). In contrast, only some loosely distributed collagen remnants were found at the
surfaces of the xenogeneic bone blocks (Figure 1B,D,F and Figure 3C). The SEM analysis showed that
island-like areas that seemed to originate from the added polymer were observable in case of the
xenogeneic SMARTBONE® block (Figure 1F), while the maxgraft® bone block exhibited a fibrillar
surface texture (Figure 1E).
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Figure 1. Scanning electron microscopy (SEM) images of the two bone blocks. The analysis revealed 
that the maxgraft® block (black asterisks = calcified bone matrix) contained high amounts of 
intertrabecular collagen (blue asterisks) (A and C), while only some collagen spots (blue arrow) were 
found in case of the SMARTBONE® block (B and D). Moreover, the SEM analysis showed that the 
maxgraft® bone block exhibited a fibrillar surface texture (E), while island-like areas of the added 
polymer (red asterisks in F) and some loosely distributed collagen fibers were observable in case of 
the SMARTBONE® block (A and B: 50× magnification, C and D: 100× magnification, E and F: 2000× 
magnification). 
. i electron microscopy (SEM) images of the two b ne blocks. The analysis revealed that
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in F) and some loosely distributed collagen fibers were observable in case of the SMARTBONE® block
(A and B: 50×magnification, C and D: 100×magnification, E and F: 2000×magnification).
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Figure 2. Representative histological images of the ultrastructure of the allogeneic maxgraft® bone 
block. (A) Overview of the bone block that shows its trabecular structure (black asterisks = trabeculae). 
Within the trabecular interspaces, high amounts of collagen were overserved (blue asterisks) 
(Masson–Goldner staining, “total scan”, 10× magnification). (B) maxgraft® shows a lamellar bone 
matrix organization. No signs of cells or cell remnants were detected within the osteocyte lacunae 
(green arrow heads) nor adherent to the outer surfaces of the bone matrix (Masson–Goldner staining, 
40× magnification, scale bar = 10 µm). (C) Within the trabecular interspaces (black asterisk = trabecula) 
collagenous structures (blue asterisks) were observable (hematoxylin and eosin (HE)-staining, 40× 
magnification, scale bar = 10 µm). 
i 2. Representative histological images of the ultrast ucture of the allogeneic maxgraft® bone bl ck.
(A) Overview of the bone block that shows its trabecular str cture (black asterisks = trabeculae). Within
the trabecular interspaces, high amounts of collagen were overserved (blue asterisks) (Masson–Goldner
staining, “total scan”, 10×magnification). (B) axgraft® shows a lamellar bone matrix organization.
No signs of cells or cell remnants were detected within the osteocyte lacunae (green arrow heads)
nor adherent to the outer surfaces of the bone matrix (Masson–Goldner staining, 40×magnification,
scale bar = 10 µm). (C) Within the trabecular interspaces (black asterisk = trabecula) collagenous
structures (blue asterisks) were observable (hematoxylin and eosin (HE)-staining, 40×magnification,
scale bar = 10 µm).
Based on these new results, both bone blocks are comparable to the bone blocks of group 2 from
the previously conducted study, which means that the level of purification as well as the preservation
of the bone matrix is similar to the DIZG Human Spongiosa block [6]. However, the purification level
of both bone blocks seems to be more favorable as not only the “intact” calcified bone matrix was
detected but also tissue-specific collagen, especially in case of the maxgraft® blocks. Thus, the former
classification of bone blocks must be revised and three new groups regarding the quality standards
need be added (Table 1).
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Figure 3. Representative histological images of the ultrastructure of the xenogeneic SMARTBONE® 
bone block. (A) The bone block shows a trabecular structure (asterisks = trabeculae). Within the 
trabecular interspaces, high numbers of matrix fragments were overserved (arrows) (Sirius red-
staining, “total scan”, 10× magnification). (B) SMARTBONE® shows a lamellar bone matrix 
organization. No signs of cells or cell remnants were detected within the osteocyte lacunae (green 
arrow heads) nor adherent to the outer surfaces of the bone matrix (Giemsa staining, 40× 
magnification, scale bar = 10 µm). (C) Within the trabecular interspaces (black asterisk = trabecula) 
collagenous structures (blue asterisks) were identifiable (Sirius red staining, 60× magnification, scale 
bar = 1 µm). 
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of the bone matrix is similar to the DIZG Human Spongiosa block [6]. However, the purification level 
of both bone blocks seems to be more favorable as not only the “intact” calcified bone matrix was 
detected but also tissue-specific collagen, especially in case of the maxgraft® blocks. Thus, the former 
classification of bone blocks must be revised and three new groups regarding the quality standards 
need be added (Table 1). 
Table 1. Revised classification of available natural blocks for bone regeneration. 
Figure 3. Representative histol gical images of t lt structure of the xenog neic SMARTBONE®
bone block. (A) The bone block shows a trabecular structure (asterisks = trabeculae). Within the
trabecular interspaces, high numbers of matrix fragments were overserved (arrows) (Sirius red-staining,
“total scan”, 10×magnification). (B) SMARTBONE® shows a lamellar bone matrix organization. No
signs of cells or cell remnants were detected within the osteocyte lacunae (green arrow heads) nor
adherent to the outer surfaces of the bone matrix (Giemsa staining, 40×magnification, scale bar = 10 µm).
(C) Within the trabecular interspaces (black asterisk = trabecula) collagenous structures (blue asterisks)
were identifiable (Sirius red staining, 60×magnification, scale bar = 1 µm).
Table 1. Revised classification of available natural blocks for bone regeneration.
Group/Class LamellarStructure
Tissue-Specific
Collagen
Organic/Cell
Remnants in
the Trabeculae
Organic/Cell
Remnants on
Trabeculae
CYTOCOMPATIBILITY Bone SubstituteMaterial
1 - - - - (?) Bio-Oss® Spongiosa
2 + + - - + maxgraft
®,
SMARTBONE®
3 + - - - (?) DIZG HumanSpongiosa
4 + - + - (?) Tutobone®
5 + - + + (?)
Puros® Allograft
Spongiosa,
OsteoBiol® Sp
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3.2. Cytocompatibility Analysis
According to EN ISO 10993-5:2009, values ≥ 70% relative to the negative control in the XTT and
BrdU assays and values ≤ 130% of the negative control in the LDH assay display the nontoxic range
(Figure 4) [8]. In the BrdU and XTT assays, the values for maxgraft® and SMARTBONE® were within
the nontoxic range (Figure 4A,B).
 
Figure 4. Cytocompatibility results of the different variants. (A) Viability measured by a BrdU assay; 
(B) proliferation measured by a Sodium 3,3′-[1(phenylamino)carbonyl]-3,4-tetrazolium]-3is(4-
methoxy-6-nitro) benzene sulfonic acid hydrate (XTT)-assay; (C) cytotoxicity measured by a lactate 
dehydrogenase (LDH) assay. Values are normalized against the respective negative control. Means 
with error bars indicate standard deviations. The dotted line indicates thresholds which should not 
be exceeded (LDH) or fall below (XTT; BrdU). Significant differences are indicated as described in the 
results section. 
4. Discussion 
The purification of the precursor tissue of natural biomaterials is of particular importance to 
prevent adverse clinical events such as graft rejection due to immunogenic interactions with 
components such as cells or transmission of pathogens [4,9–11]. In this context, the different available 
bone blocks are produced on basis of varying purification processes with different purification efforts 
Figure 4. Cytocomp t results of the different variants. (A) Viability measured by a BrdU
assay; (B) proliferation m asured by a Sodium 3,3′-[1(phenylamino)carbonyl]-3,4-tetrazolium]-
3is(4-methoxy-6-nitro) benzene sulfonic acid hydrate (XTT)-assay; (C) cytotoxicity measured by
a lactate dehydrogenase (LDH) assay. Values are normalized against the respective negative control.
Means with error bars indicate standard deviations. The dotted line indicates thresholds which should
not be exceeded (LDH) or fall below (XTT; BrdU). Significant differences are indicated as described in
the results section.
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In the BrdU assay, maxgraft® showed slightly lower results compared to the negative control,
while SMARTBONE shows slightly higher results (Figure 4A). Thereby, maxgraft® exhibited significant
differences compared to the negative control (p ≤ 0.013) as well as to the SMARTBONE® material
(p ≤ 0.008).
In the XTT assay, both test groups exhibited slightly higher results compared to the negative
control, with highest values for maxgraft® (Figure 4B). Thereby, the values for maxgraft® were
significantly different compared to the negative control (p ≤ 0.02), while the values for SMARTBONE®
did not show any significant differences to this control group (Figure 4B).
In the LDH assay, both test groups marginally exceeded the toxic limit, but showed no significant
differences to the negative control (Figure 4C). Thereby, the standard variances of the maxgraft®
material were higher than for the SMARTBONE® material (maxgraft: 44%, SMARTBONE: 1.7%).
In all assays, the values of the positive control materials were highly significant different to the
other test samples (p ≤ 0.02 or lower).
4. Discussion
The purification of the precursor tissue of natural biomaterials is of particular importance to
prevent adverse clinical events such as graft rejection due to immunogenic interactions with components
such as cells or transmission of pathogens [4,9–11]. In this context, the different available bone blocks
are produced on basis of varying purification processes with different purification efforts [7]. Although
all materials have been proven to fulfil the provisions of the respective norms, it has been shown that
the purification results are widely differing [7]. In this context, a study of Ghanaati and Barbeck et
al. including five commercially available allo- or xenogeneic bone blocks has been conducted that
focused on their ultrastructure and the detection of cellular or organic matrix components based on
easily applicable histological methods [7]. Interestingly, the results showed that three out of the five
bone blocks contained cells or cell remnants, which led to the conclusion that these materials differ in
the desired material composition originally targeted by the manufacturer and which is mandatory by
different regulations and laws. In this study, the investigated test samples were divided into 4 groups
according to the ultrastructures of bone matrix, remnants of collagen and cells. The classification can be
distinguished as follows: complete purification of the bone matrix with a loss of the lamellar structure
and without the presence of collagen as well as conservation of all previously mentioned structures.
In the present study, two other bone blocks were comparably analyzed, that is, the allogeneic
block maxgraft® and the xenogeneic block SMARTBONE®, using the same histological methods.
Furthermore, cytocompatibility and physical characteristics were determined using different extract
assays and SEM. Altogether, the microscopic results show that both bone blocks exhibit a trabecular
structure with a lamellar suborganization. No cells or cellular remnants were found nor associated
with the calcified bone matrix nor with the intertrabecular collagen matrix. Thus, both bone blocks
and their underlying purification processes does not seem to differ in view of the successful removal
of immunogenic components. However, the microscopic analyses revealed that the purification of
both bone blocks differed with regard to their collagen contents. High amounts of the intertrabecular
collagenous matrix were observable in case of the allogeneic bone blocks, while only some loosely
distributed collagen remnants were found at the surfaces of the xenogeneic bone blocks. Additionally,
the SEM analysis showed that island-like areas that seemed to originate from the added polymer were
observable in case of the xenogeneic SMARTBONE® block, while the maxgraft® bone block exhibited
a fibrillar surface texture.
Furthermore, a few fragments of the bone matrix were observable within the trabecular interspaces
in case of the allogeneic bone block, while within the intertrabecular interspaces of the xenogeneic
bone block, high numbers of matrix fragments were observed.
Finally, the in vitro cytocompatibility analyses showed that both materials were fully
cytocompatible, although the values in the LDH assay slightly exceeded the toxic limit. In this
context, it should be mentioned that the LDH assay exhibits high sensitivity and the results should
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be compared with both the XTT and BrdU assays, which was already described by Jung et al. [8].
Thereby, since both materials showed favorable cytocompatibility in the XTT and BrdU assays, in
connection with the slightly increased values in the LDH assays, an overall sufficient cytocompatibility
can be assumed.
Based on these new results both bone blocks are comparable to the bone blocks of group 2 from
the previously conducted study, which means that the level of purification as well as the preservation
of the bone matrix is similar to the DIZG Human Spongiosa block [6]. However, the purification level
of both bone blocks seems to be more favorable as not only was the “intact” calcified bone matrix
detected but also tissue-specific collagen, especially in case of the maxgraft® blocks. Thus, the former
classification of bone blocks must be revised and three new groups regarding the quality standards
need be added (Table 1).
Altogether, the presented results show that the analyzed bone blocks have the highest level of
purification, as both the calcified matrix and bone tissue-specific collagen were found without any
signs of remaining cells or cell remnants.
However, the contained collagen in case of the maxgraft® bone block is of special interest for the
(bone) regeneration process as it has been revealed in a broad variety of studies that this molecule
enables enhancement of the cell activity of bone cells and other related cell types, such as endothelial
cells, and thus osteogenesis [5]. In general, collagen is necessary for wound healing and thus it is
conceivable that both analyzed bone blocks may optimally support the regeneration of bone tissue
even in dentistry but also in other applications such as orthopedics or traumatology [5]. However,
this did not result in higher values in the extract cytocompatibility assays since L929 cells were used
and were not directly seeded onto the materials. Furthermore, the composition of the extracts was not
determined whether collagen or other native materials have been extracted. In this context, it should
be noted that the analyzed maxgraft® block is produced by the Cells + Tissuebank Austria (C+TBA)
that also provides bone blocks or bone substitutes for these latter applications. Interestingly, it has
been revealed in different studies that these biomaterials allow for successful bone tissue repair [15,17].
However, further studies that include molecular biological methods should be conducted to analyze
the impact of the described results on the process of bone tissue regeneration.
A further interesting result was found in the presence of high numbers of matrix fragments in
case of the SMARTBONE® block. In this context, it was also shown that such matrix fragments, which
were also found in case of the xenogeneic bone substitute material Bio-Oss®, can induce a fast and high
implant bed vascularization, which might support the regeneration process [18]. Interestingly, these
fragments may induce multinucleated giant cells that have also been detected associated to different
other biomaterials and bone substitutes [9,10,18–20]. Moreover, it has been revealed that these cells
seem to be of the foreign body giant cell phenotype, and they express both pro- and anti-inflammatory
molecules [21]. Additionally, it has been shown that this cell type expresses the vascular endothelial
growth factor (VEGF), which is a key element of the angiogenesis process within a tissue and a
promoting factor of osteoblast differentiation and proliferation [22]. Thus, it is conceivable that the
application of the SMARTBONE® block might result in satisfying clinical results by supporting the
bone regeneration process on its molecular level.
Altogether, the analysis of the purification effort of both bone blocks showed that it is possible
to combine the purification from cells and other immunogenic components with preservation of the
bone matrix ultrastructure and the bone tissue-specific collagen. Further studies should analyze the
biological activity of the included collagen and the bone matrix fragments and its consequences for
the bone healing process. Furthermore, the present study results revealed that SEM investigations
and cytocompatibility measurements should also be included in the preclinical evaluation of the
biocompatibility of bone blocks and should be complemented by direct cell assays and the determination
of extract composition.
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5. Conclusions
In the present study, two further bone blocks of both allogeneic and xenogeneic origin were
microscopically analyzed with special focus on their composition and ultrastructure, as well as on
possible cell or tissue remnants. The analysis showed that both bone blocks were completely free of
cellular remnants and only some collagen-like structures as well as remnants of the polymer of the
SMARTBONE® block were found. Both materials were cytocompatible according EN ISO 10993-5:2009.
Overall, the level of purification of the maxgraft® block appears to be favorable because only “intact”
calcified bone matrix and higher amounts tissue-specific collagen could be detected.
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